Philip S. Low
Next Generation Targeted Therapeutics
Research Areas
Phase 3 human clinical trials of Malaria
Acceleration of bone fracture repair
Development of new therapies for malaria
Design of ligand-targeted drugs
Tumor-targeted dyes for fluorescence-guided surgery of cancer
Development of novel immunotherapies for cancer
Novel imaging and therapeutic agents for automimune diseases
Design of new therapies for sickle cell disease
Design of targeted anti-viral therapies
Targeted control of cell-based therapeutics
Drug targeting to the tumor microenvironment
Structural characterization of the human red blood cell membrane
Pharmacologic control of neurotransmitter transporters